129 related articles for article (PubMed ID: 10743081)
1. [Apoptosis-antagonizing protein Bcl-2 expression, distribution in non-Hodgkin's lymphoma and its clinical significance].
Chen X; Huang G; Wang W
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):140-2. PubMed ID: 10743081
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
4. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
5. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
Chen XQ; Wang WL; Huang GS
Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
8. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
9. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases.
Agarwal B; Naresh KN
Am J Hematol; 2002 Aug; 70(4):278-82. PubMed ID: 12210808
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
12. [The expression and clinical significance of proliferative antigen Ki-67 and apoptosis-antagonizing antigen Bcl-2 in non-Hodgkin's lymphoma].
Xu W; Sheng R; Zheng Z; Xu T
Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):452-5. PubMed ID: 11798613
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
14. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
15. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
16. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.
Cornfield DB; Mitchell DM; Almasri NM; Anderson JB; Ahrens KP; Dooley EO; Braylan RC
Am J Clin Pathol; 2000 Aug; 114(2):258-63. PubMed ID: 10941341
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.
Kovalevska LM; Yurchenko OV; Shlapatska LM; Berdova GG; Mikhalap SV; Van Lint J; Sidorenko SP
Exp Oncol; 2006 Sep; 28(3):225-30. PubMed ID: 17080017
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
Kondo E; Yoshino T; Yamadori I; Matsuo Y; Kawasaki N; Minowada J; Akagi T
Am J Pathol; 1994 Aug; 145(2):330-7. PubMed ID: 7519826
[TBL] [Abstract][Full Text] [Related]
19. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Alas S; Emmanouilides C; Bonavida B
Clin Cancer Res; 2001 Mar; 7(3):709-23. PubMed ID: 11297268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
